MDL | Jotup

Identity & Access Forum Launches Industry’s First Template for Building Mobile Driver’s License Use Cases

Retrieved on:

水曜日, 4月 17, 2024

Ecosystem, String interpolation, Law enforcement, Government, Organization, MDL, Privacy, IDS, Access, RPS, ID, Identity, Internet access, Risk management

In the U.S., the secure, cryptographically protected, digital identity credential is available in six states, representing more than 66 million people.

Key Points:

In the U.S., the secure, cryptographically protected, digital identity credential is available in six states, representing more than 66 million people.
In response, the Secure Technology Alliance’s Identity and Access Forum has launched the industry’s first mDL use case template.
To that end, the Secure Technology Alliance and its Identity and Access Forum have been instrumental in driving forward the implementation of mDLs,” said Sandy Mayfield, managing director of the Identity and Access Forum.
The template was created by the Identity and Access Forum’s Jumpstart Committee, a subcommittee of the Digital Identity Working Committee.

Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization

Retrieved on:

水曜日, 5月 1, 2024

“The Plan is the culmination of our consensual resolution strategy that we announced last October,” said Erik Haas, Worldwide Vice President of Litigation, Johnson & Johnson.

Key Points:

“The Plan is the culmination of our consensual resolution strategy that we announced last October,” said Erik Haas, Worldwide Vice President of Litigation, Johnson & Johnson.
The remaining pending personal injury lawsuits relate to mesothelioma and will be addressed outside of the Plan.
The State consumer protection claims will also be addressed outside the Plan; the Company already has agreements in principle to do so.
In light of those risks, counsel representing the overwhelming majority of current ovarian claimants assisted in the development and support the Plan.

Beasley Allen Law Firm: Attorneys for Women Harmed by Johnson & Johnson’s Talcum Powder Resist Company’s Attempt to Stuff Ballot Box in Unprecedented Third Attempted Bankruptcy

Retrieved on:

水曜日, 5月 1, 2024

Legal, Professional Services, J&J, Asbestos, Mesothelioma, Cancer, Woman, Bankruptcy, Bankruptcy Code, MDL, Ashcraft, Medicine, Action Replay, Talc, Lawyer, Ovarian cancer, Insurance

Now the company promises minimal payments for these “worthless” claims in exchange for a “yes” vote.

Key Points:

Now the company promises minimal payments for these “worthless” claims in exchange for a “yes” vote.
Medical costs for treating ovarian cancer can total more than $1.5 million per patient, with an average near $220,000.
In October 2021, at the time of the first J&J/LTL bankruptcy, there were approximately 35,000 lawsuits alleging talc-caused ovarian cancer or mesothelioma.
“This will be the third bankruptcy in three years,” noted trial lawyer Richard Golomb , of Golomb Legal P.C.

Four Out of Five Americans Believe Passwords Do Not Secure Access to Banking and Government Digital Services

Retrieved on:

水曜日, 5月 1, 2024

Four out of five (79%) Americans believe there must be a more secure solution than passwords to access important sites like banking and government services.

Key Points:

Four out of five (79%) Americans believe there must be a more secure solution than passwords to access important sites like banking and government services.
As more high-value consumer services are delivered online, evidence of Americans’ concerns over the security of how they access these services has grown.
Seven in ten (70%) Americans no longer trust passwords to verify their identity online and believe a more reliable solution is needed.
If organizations can’t provide secure online services, financial and reputational losses will reduce the competitiveness of commercial enterprises and limit the equal accessibility of government services.

Napoli Shkolnik Applauds EPA’s Designation of PFOA and PFOS as Hazardous Substances Under CERCLA

Retrieved on:

月曜日, 4月 22, 2024

Napoli Shkolnik supports the Environmental Protection Agency’s (“EPA”) recent decision to classify Perfluorooctanoic Acid (“PFOA”) and Perfluorooctane Sulfonate (“PFOS”) as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”).

Key Points:

Napoli Shkolnik supports the Environmental Protection Agency’s (“EPA”) recent decision to classify Perfluorooctanoic Acid (“PFOA”) and Perfluorooctane Sulfonate (“PFOS”) as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”).
By recognizing PFOA and PFOS as hazardous, the EPA has set a stage for more effective regulatory actions and remediation efforts, ensuring better protection for communities adversely affected by these persistent environmental pollutants.
Paul J. Napoli, Partner at Napoli Shkolnik remarked “This is a monumental step forward in our ongoing fight against these pollutants.
As the EPA implements this new designation Napoli Shkolnik is prepared to assist and represent all those affected by exposure to these chemicals.

Napoli Shkolnik’s Paul Napoli and AFFF MDL Co-Leads Secure $750 Million Settlement with Tyco Fire Products LP in AFFF MDL

Retrieved on:

金曜日, 4月 12, 2024

Professional Services, Legal, Environment, Public, PFAS, Tyco, District court, Drinking water, The Honourable, MDL, Water

In a monumental stride towards addressing the nation’s PFAS water contamination crisis, Paul Napoli, along with the co-leads of the AFFF Multi-District Litigation, have achieved a groundbreaking $750 million settlement with Tyco Fire Products LP.

Key Points:

In a monumental stride towards addressing the nation’s PFAS water contamination crisis, Paul Napoli, along with the co-leads of the AFFF Multi-District Litigation, have achieved a groundbreaking $750 million settlement with Tyco Fire Products LP.
This significant legal triumph will facilitate the remediation of drinking water sources for public water systems impacted by PFAS, a group of harmful chemicals found in AFFF.
“Securing this settlement is a testament to our collective resolve to address and mitigate the impact of PFAS contamination,” said Napoli Shkolnik Partner Paul Napoli.
The agreement marks a critical step forward in the ongoing legal and environmental advocacy efforts to combat PFAS contamination.

Baron & Budd Obtains Settlement With Tyco Fire Products in PFAS Water Contamination Litigation

Retrieved on:

金曜日, 4月 12, 2024

Today, Baron & Budd announced that a $750 million settlement agreement has been reached with Tyco Fire Products to resolve PFAS-related drinking water contamination claims in the nationwide Aqueous Film-Forming Foam (AFFF) Products Liability Litigation (MDL 2873).

Key Points:

Today, Baron & Budd announced that a $750 million settlement agreement has been reached with Tyco Fire Products to resolve PFAS-related drinking water contamination claims in the nationwide Aqueous Film-Forming Foam (AFFF) Products Liability Litigation (MDL 2873).
The settlement will provide funds to public water systems in the U.S. that tested and found PFAS at any level on or before May 15, 2024.
This agreement comes on the heels of the Environmental Protection Agency’s (EPA) announcement of the strict federal drinking water standards that will regulate PFAS levels in public water supplies.
The PFAS chemicals in AFFF are often referred to as “forever chemicals” because they do not easily break down and they are extremely water soluble, meaning they spread quickly in water.

Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid

Retrieved on:

月曜日, 4月 15, 2024

Allocation, Drug, Hearing, McKinsey & Company, Medicaid, MDL, Opioid, Medicare Advantage, Court, Medicare, Settlement, Health insurance

Third-Party Payors: If you paid or reimbursed costs for prescription opioids, or paid or incurred costs for treatment related to opioid misuse, addiction, and/or overdose,

Key Points:

Third-Party Payors: If you paid or reimbursed costs for prescription opioids, or paid or incurred costs for treatment related to opioid misuse, addiction, and/or overdose,
You Could Get Money from a Settlement.
Your rights may be affected by the proposed Settlement in a class action lawsuit with McKinsey & Company, Inc. ("McKinsey").
A more detailed notice, including the full class definition and who is not included, is available at www.McKinseyTPPSettlement.com .
A $78 million Settlement Fund will pay money to eligible Class Members, notice and administration costs up to $1 million, and attorneys' fees, costs, and expenses.

Everlaw and International Litigation Services Announce Strategic Partnership

Retrieved on:

火曜日, 3月 19, 2024

Everlaw , the cloud-native investigation and litigation platform, today announced a multi-year strategic partnership with the plaintiffs’ ediscovery firm, International Litigation Services (ILS).

Key Points:

Everlaw , the cloud-native investigation and litigation platform, today announced a multi-year strategic partnership with the plaintiffs’ ediscovery firm, International Litigation Services (ILS).
Together, the companies’ offerings will enable best-in-class services on the Everlaw platform for the plaintiffs bar, helping clients chart a straighter path to the truth.
“ILS gives plaintiffs’ firms the leading edge when it comes to everything ediscovery, and we’re excited that our new partnership with Everlaw will extend that opportunity.”
Everlaw and ILS are partnering on a high-profile, high-impact multi-district litigation case.
“Plaintiff firms look to ILS to deliver critical expertise, skills and project management, and with Everlaw, they’ll access best-in-class ediscovery services for both quality and speed.

Lex Machina Releases 2024 Antitrust Litigation Report

Retrieved on:

木曜日, 4月 4, 2024

Lex Machina, California Department, Agriculture, Latham & Watkins, Research, LexisNexis, Food, Software, MDL, DOJ, Justice, Partner

MENLO PARK, Calif., April 4, 2024 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Antitrust Litigation Report. The report examines antitrust litigation trends in federal district and appellate courts. Focusing on the three-year period from 2021 to 2023, it surveys emerging trends in case filings, venues, judges, law firms, parties, timing metrics, case resolutions, findings, and damages. The report often focuses on different sets of data, e.g., filtering cases in order to provide analytics on general antitrust cases, DOJ/FTC enforcement contested cases, MDL Master cases, antitrust class action cases, and federal appellate cases.

Key Points:

In the last three years, various subsets of antitrust litigation have exhibited a similar case filing pattern consisting of a drop in 2022 followed by a rebound in 2023
MENLO PARK, Calif., April 4, 2024 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Antitrust Litigation Report.
The report examines antitrust litigation trends in federal district and appellate courts.
"Antitrust is a complex area of litigation that includes different subsets of cases as well as significant numbers of MDL cases," said Ron Porter, Lex Machina's antitrust legal data expert and editor of the report.
Register here for a copy of the report: https://pages.lexmachina.com/2024-Antitrust-Report_LP.html
Lex Machina is hosting a webcast to discuss the report on April 4, 2024 at noon ET/9am PT with Anna Rathbun (Partner at Latham & Watkins), Ron Porter (Lex Machina's Legal Data Expert in Antitrust Litigation), and Aria Nejad (Lex Machina's in-house counsel).